Pharmaceuticals

Bio Roundup: DIY Biohacking, PCSK9 Data, Solid Setback & More

One year ago   |   By Xconomy

Drug prices are top of mind for many patients. Some of them have to cut back on basic needs just to pay for treatments that seem to rise in price each year. That made a recent announcement by Regeneron Pharmaceuticals particularly unusual. The Tarrytown, NY, drugmaker plans to cut the price of its cholesterol-lowering drug alirocumab if it can get concessions from payers. Regeneron made the move after data from a heart study suggested its drug might reduce the risk of death in those who have recently suffered a heart attack or stroke, and are at high risk of having...
Read more ...

 


Search by Tags

   Pharmaceuticals      Pharmaceutical      Drugs      Drug      Boston blog main      Boston top stories      Boulder      Denver blog main      Denver top stories      Detroit blog main      Detroit top stories      National      National blog main      National top stories      New York blog main      New York top stories      Raleigh-Durham blog main      Raleigh-Durham top stories      San Diego blog main      San Diego top stories      San Francisco blog main      San Francisco top stories      Seattle blog main      Seattle top stories      Texas blog main      Texas top stories      Acromegaly      Advaxis      Akcea Therapeutics      Alexion Pharmaceuticals      Alirocumab      Alnylam Pharmaceuticals      Arbor Biotechnologies      Arcus Biosciences      AstraZeneca      Auris Medical      Biogen      Biotech      Bischofberger      Cigall Kodach      Clinical trials      Contrave      Crinetics      CRISPR      CRISPR-Cas9      Dana-Farber Cancer Institute      Duchenne Muscular Dystrophy      Durvalumab      Elizabeth Holmes      FDA      Flagship Pioneering      Foghorn Therapeutics      Food and Drug Administration      Gilead Sciences      GlaxoSmithKline      Golodirsen      Humacyte      Ideaya Biosciences      Intra-Cellular Therapies      IPO      Josiah Zayner      Keyzilen      Life Sciences      Lumateperone      Norbert      Orexigen Therapeutics      Paroxysmal nocturnal hemoglobinuria      Pfizer      Ramesh Balwani      Regenerative Medicine      Regeneron Pharmaceuticals      Sanofi      Sarepta Therapeutics      Schizophrenia      Securities and Exchange Commiossion      Securities and Exchange Commission      Solid Biosciences      Startups      Theranos  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Encoded Nabs $104M, Illumina's Help, to Push Gene Therapy's Limits

Encoded Nabs $104M, Illumina's Help, to Push Gene Therapy's Limits

Despite the progress of gene therapy-a cutting edge medicine promising long-lasting effects from a single treatment-it remains a crude and limited tool. Startup Encoded... Read more ...

Acutus, Maker of Next-Gen Electrophysiology Tech, Adds $100M Series D

Acutus, Maker of Next-Gen Electrophysiology Tech, Adds $100M Series D

A company that makes a mapping system to help doctors see high-resolution, 3D images of irregular heart rhythms in real time has raised $100 million in venture investment and a... Read more ...

Scientists Hit Pay Dirt with New Microbial Research Technique

Scientists Hit Pay Dirt with New Microbial Research Technique

Credit: Susan Brand and Marilyn Chung/Berkeley Lab Long ago, during the European Renaissance, Leonardo da Vinci wrote that we humans “know more about the movement of celestial... Read more ...

XLerate Health Launches Early-Stage Startup Accelerator in Flint

XLerate Health Launches Early-Stage Startup Accelerator in Flint

Anyone who has followed the Flint water crisis for the past few years probably thinks of the post-industrial Michigan city as a place that can't seem to catch a break. Five... Read more ...

A New View of Alzheimer's

A New View of Alzheimer's

As we age and forget why we walked into a particular room, we may joke about our incipient “Alzheimer's.” But Alzheimer's disease is no joke. It's a deadly and devastating... Read more ...

Hate to Pump Gas? Booster Scores $56M to Scale Mobile Fill-Ups

Hate to Pump Gas? Booster Scores $56M to Scale Mobile Fill-Ups

Booster , an on-demand service that fills gas tanks for car owners while they shop at a mall or work at their office desks, announced Tuesday it has raised $56 million to... Read more ...

Broad, Berkeley Return to Argue CRISPR Invention at Patent Office

Broad, Berkeley Return to Argue CRISPR Invention at Patent Office

A special board of the US Patent and Trademark Office has reignited the long-running patent fight over who invented the groundbreaking CRISPR-Cas9 gene editing system. Nearly a... Read more ...

Led by Tech, Healthcare Debuts, IPOs in 2019 Show Positive Returns

Led by Tech, Healthcare Debuts, IPOs in 2019 Show Positive Returns

Even as Uber, Lyft, and other high-profile initial public offerings underperformed out of the gate, the average share price of companies that have gone public in the US this... Read more ...

Funds for Phlur, Arrive Logistics, Aunt Bertha & More TX Tech News

Funds for Phlur, Arrive Logistics, Aunt Bertha & More TX Tech News

Let's catch up with the latest innovation news in Texas. -Austin-based fragrance maker Phlur raised $7 million in a Series A round, the company announced. The investment was... Read more ...

Everactive Snags $30M Series C to Advance Battery-less IoT Sensors

Everactive Snags $30M Series C to Advance Battery-less IoT Sensors

Everactive , a Bay Area startup, has raised $30 million in a Series C funding round. The investment was led by Future Fund with participation from Blue Bear Capital , ABB... Read more ...